摘要
目的应用蒙脱石散加锡类散治疗慢性糜烂性胃炎以观察其临床效果。方法选择2007年1月至2009年12月门诊和部分住院慢性糜烂性胃炎患者92例。根据随机对照原则,将患者分为治疗组和对照组各46例,两组患者年龄、性别和病程等无统计学差异,具有可比性(P>0.05)。全部患者均在治疗原发病基础上,采取适当饮食控制,休息,必要时给予对症治疗和输液。慢性糜烂性胃炎治疗组采用蒙脱石散。对照组在一般治疗基础上,口服法莫替丁20 mg,2次/d,疗程1周。两组患者均在疗程前和治疗1周后复查胃镜,并观察患者临床症状及服药反应等。结果慢性糜烂性胃炎治疗组46例,总有效率100%;对照组46例,总有效率63.0%。与对照组比较,治疗组明显优于对照组(P<0.05)。两组治疗期间均无明显不良反应。结论蒙脱石散加锡类散治疗慢性糜烂性胃炎具有服用方便、成本低及疗效好的优点,可以在门诊或中小医院使用。
Objective To analysis of smectite powder matching Xileisan in treatment for the patients with chronic erosive gastritis.Methods Chooses outpatient and the part in hospital for 92 patients with chronic erosive gastritis from January 2007 to December 2009,according to the principle of stochastic control,the patients were divided into the treatment group（n=46）and the control group（n=46）,two groups of patients have the commeasurability（P0.05）.There was in therapy primary disease for the patients,and adopts the suitable diet control,the rest,and wants when gives symptomatic treatment and the infusion.The treatment group uses smectite powder.Control group in general treatment foundation,oral famotidine 20 mg,two times a day and treatment course was 1 week.After treatment 1 week,two groups of patients were inspected by gastroscope,and observe the patient clinical symptom and take medicine the response and so on.Results In treatment group 46 patients,the total effect was 100%.In control group 46 patients,the total effect was 63.0%.Compared with the control group,treatment group was significantly better than the control group（P0.05）.There was no obvious side effect in two groups,but normally well tolerated.Conclusion The data showed that smectite powder matching Xileisan in treatment for the patients with chronic erosive gastritis to have takes convenient,the cost low and the curative effect good,and make use of the patients in outpatient or the small hospital.
出处
《医学综述》
2011年第4期622-623,共2页
Medical Recapitulate
